What are bisaramil drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

bisaramil drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

bisaramil

0 marketed 1 in Phase 2

This page covers all bisaramil drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 2 pipeline (1)

Alpha-Yutac · Other
Alpha-Yutac works by binding to a specific target, but the exact mechanism is not well understood.

Patent intelligence

bisaramil patent landscape — aggregated cliff calendar, attackable patents, originator estates